Update on the HTA Coordination Group subgroup m...

By HEOR Staff Writer

April 28, 2023

Update on the HTA Coordination Group subgroup meetings held on April 25 and 26. Their collective efforts will surely shape the HTA landscape in the long run.
Tezepelumab as an Add-on Maintenance Treatment for Severe Asthma: Recommendat...
Clinical evidence shows that AposHealth (an FDA-cleared medical device) impro...
Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Go...
Chronic Heart Failure: PBAC Recommends Empagliflozin
Iberian Healthcare Collaboration: Spain & Portugal Unite for Health Tech...
Global Pull Incentive Needed to Future-Proof Antibiotic Innovation, Says OHE ...
Genedrive MT-RNR1 ID Kit to detect genetic variation and protect hearing in b...
DARWIN EU® is calling for new data partners
Did CVDs recover post COVID-19 ?
Multiple myeloma is the second most common type of blood cancer, with approxi...
The evidence for Cannabidiol is building
HTA must consider health equity for progress